A Taiwan-made vaccine for the H7N9 strain of avian flu is expected to begin mass production in June this year after completing human trials, Taichung-based Adimmune Corp. said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan's Central Bank opens IG account to connect with young people
05/06/2024 09:24 PM - Cross-Strait
3 Taiwanese found guilty of illegally working for Chinese firm
05/06/2024 08:59 PM - Business
TSMC largest R&D spender among listed manufacturers in Taiwan
05/06/2024 08:32 PM - Politics
MOFA defends deal to provide Ukraine aid via Czech NGO
05/06/2024 08:24 PM - Society
Indigenous activist to end 7-year protest camp on inauguration day
05/06/2024 07:58 PM